Ledger.Open graph →
SEC Form D · filed August 1, 2024

Autobahn Therapeutics, Inc

Offering
$120.0M
Sold
$100.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Kristina D. Burow · San Diego, CADirectorBenjamin Cravatt · San Diego, CADirectorKristina D. Burow · San Diego, CADirectorUwe J. Schoenbeck · San Diego, CADirectorJohn Borkholder · San Diego, CAExecThomas Cahill · San Diego, CADirectorTimothy Anderson · Boca Raton, FLDirectorPhilip J. Desouza · San Diego, CADirectorScott Giacobello · Pacific Palisades, CADirectorKevin Finney · Campbell, CAExec · DirectorBonnie J. Van Wilgenburg · San Diego, CADirectorJustin W. Banulski · SAN FRANCISCO, CADirectorUwe J. Schoenbeck · San Diego, CADirectorJohn Borkholder · Santa Clara, CAExecThomas Cahill · San Diego, CADirectorTimothy Anderson · San Diego, CADirectorPhilip J. Desouza · San Diego, CADirectorBenjamin Cravatt · San Diego, CADirectorScott Giacobello · Pacific Palisades, CADirectorKevin Finney · San Diego, CAExec · DirectorBonnie J. Van Wilgenburg · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗